Market Overview

Zogenix to Host Conference Call Following FDA Panel Meeting, Will Be at 6:30PM

Share:
Related ZGNX
Zogenix Received FDA Approval, Now What?
What Investors Are Watching Ahead of Zogenix's FDA Approval Decision
FDA accepts Teva's NDA for abuse-deterrent opioid (Seeking Alpha)

Zogenix (NASDAQ: ZGNX) will host a conference call to discuss the outcome of the AADPAC meeting today, Friday, December 7, 2012 at 6:30 p.m. ET (3:30 p.m. PT). To participate, please dial (800) 299-9086 (U.S.) or (617) 786-2903 (International); participant passcode: 21970283.

Posted-In: News FDA

 

Related Articles (ZGNX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→